AKT inhibitors: a new type of targeted cancer drug 

To mark our outstanding success in REF2021 - the UK Government’s measure of the quality and impact of university research - we’re celebrating some of the research programmes that have been changing the lives of cancer patients since the most recent equivalent assessment in 2014.
Find out more: www.icr.ac.uk/...